e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predictors of progression in systemic sclerosis patients with interstitial lung disease
Oliver Distler, Shervin Assassi, Vincent Cottin, Maurizio Cutolo, Sonye K. Danoff, Christopher P. Denton, Jörg H.W. Distler, Anna-Maria Hoffmann-Vold, Sindhu R. Johnson, Ulf Müller Ladner, Vanessa Smith, Elizabeth R. Volkmann, Toby M. Maher
Source:
Eur Respir J, 55 (5) 1902026; 10.1183/13993003.02026-2019
Journal Issue:
May
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Oliver Distler, Shervin Assassi, Vincent Cottin, Maurizio Cutolo, Sonye K. Danoff, Christopher P. Denton, Jörg H.W. Distler, Anna-Maria Hoffmann-Vold, Sindhu R. Johnson, Ulf Müller Ladner, Vanessa Smith, Elizabeth R. Volkmann, Toby M. Maher. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J, 55 (5) 1902026; 10.1183/13993003.02026-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Imaging of complicated pneumonia: what is new?
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Related content which might interest you:
Disease course and outcome of progressive interstitial lung disease in systemic sclerosis
Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new?
Year: 2019
The natural course of systemic sclerosis patients with interstitial lung involvement
Source: Eur Respir J 2005; 26: Suppl. 49, 336s
Year: 2005
Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis
Source: Eur Respir J 2011; 38: 1355-1360
Year: 2011
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease
Source: Eur Respir Rev, 27 (148) 170102; 10.1183/16000617.0102-2017
Year: 2018
Longitudinal functional evaluation of interstitial lung disease in systemic sclerosis
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Clinical characteristics of interstitial lung fibrosis in progressive systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006
Anti-a-enolase antibodies in systemic sclerosis identify a subset of patients with diffuse cutaneous sclerosis and interstitial lung disease
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Association of FVC/DLCO with pulmonary hypertension risk and interstitial disease in systemic sclerosis patients
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy
Source: International Congress 2014 – ILDs 4
Year: 2014
Pulmonary physiology is poorly associated with radiological extent of disease in systemic sclerosis-associated interstitial lung disease
Source: Eur Respir J, 53 (5) 1802182; 10.1183/13993003.02182-2018
Year: 2019
Potential causes of acute deterioration in patients with interstitial lung disease
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Clinical manifestations of systemic sclerosis (SS) accompanied with pulmonary involvement
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Survival and prognostic factors in progressive systemic sclerosis with lung involvement
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
IGFBP-2: a new pathway in systemic sclerosis associated interstitial lung disease
Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new?
Year: 2019
Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept